Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function.
Patel NJ, Hoosien M, Deshmukh A, Badheka AO, Grover PM, Shah N, Singh V, Mehta K, Chothani A, Savani GT, Arora S, Bhalara V, Patel N, Khalpada D, Rathod A, Vazzana TJ, Lafferty J, Viles-Gonzalez JF, Mitrani RD.
Patel NJ, et al. Among authors: lafferty j.
Int J Cardiol. 2013 Nov 20;169(5):e84-6. doi: 10.1016/j.ijcard.2013.10.040.
Int J Cardiol. 2013.
PMID: 24377111
No abstract available.